recurrent cutaneous melanoma
Showing 1 - 7 of 7
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma, Metastatic Non-Cutaneous Melanoma Trial in Canada, Ireland, United
Active, not recruiting
- Metastatic Cutaneous Melanoma
- +15 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +582 more
Jan 28, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +5 more
- Pembrolizumab
- +2 more
-
Anchorage, Alaska
- +162 more
Aug 23, 2022
Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,
Active, not recruiting
- Metastatic Melanoma
- +2 more
- Ibrutinib
- +3 more
-
Los Angeles, California
- +12 more
Jul 27, 2022
Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Tumor Trial in Houston
Recruiting
- Recurrent Cutaneous Melanoma
- +27 more
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2021
Melanoma of Unknown Primary, Metastatic Malignant Tumor in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Melanoma of Unknown Primary
- +5 more
- Binimetinib
- +5 more
- (no location specified)
Feb 13, 2020